When it comes to a scraped knee, you probably reach for a Band-Aid. Sneeze attack? Kleenex, please! Sometimes a brand is so good, so ubiquitous, that it defines an industry. The same could be said for ...
St. Louis Practice Updates Dysport and Xeomin Treatment Planning Saint Louis, United States - May 21, 2026 / Modern Med ...
– Dysport is the first and only FDA-approved botulinum toxin for treatment of both pediatric upper and lower limb spasticity1 – – Pivotal Phase 3 study demonstrated Dysport improved spasticity ...
The DIRECTION trial addresses decades-long evidence gaps by delivering the first head-to-head, double-blind, comparative data between Dysport and Botox in adult spasticity. More broadly, these ...
Dysport is an injectable form of botulinum toxin type A (BoNT-A), which is isolated and purified from Clostridium bacteria producing BoNT-A.1 It is supplied as a lyophilized powder.1 Dysport has ...
There are now five brands of botulinum toxin type A (BTX-A): Botox, Dysport, Jeuveau, Daxxify, and Xeomin, and they all work the same way. I’m calling them “BTX-A” to represent the entire group. These ...
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) (Ipsen) today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved use of Dysport ® ...
Ipsen announced that the FDA has approved the supplemental Biologics License Application (sBLA) for Dysport (abobotulinumtoxinA) for injection for the treatment of lower limb spasticity in patients ...
Dysport 1500 Units injection was associated with a statistically significant improvement in muscle tone and spasticity at the ankle joint. The duration of response ranged between 12–16 weeks with some ...
Dysport's growth opportunities lie in the expanding neuromodulator market, driven by rising demand for minimally invasive procedures. Key prospects include leveraging competitive pricing against Botox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results